16 results match your criteria: "Clinical and Public Health Group[Affiliation]"

Objective: To explore the role of local public health organisations in antimicrobial stewardship (AMS) and antimicrobial resistance (AMR) surveillance.

Methods: A scoping review was conducted. Peer-reviewed and grey literature from countries within the organisation for economic co-operation and development was searched between 1999 and 2023 using the concepts of local public health, AMR and AMS.

View Article and Find Full Text PDF

Building on the success of pharmaceutical public health: is it time to focus on health inequalities?

Int J Pharm Pract

September 2024

Healthcare Associated Infections and Antimicrobial Resistance Division, Clinical and Public Health Group, UK Health Security Agency, London, United Kingdom.

View Article and Find Full Text PDF

H5 and H9 avian influenza - potential re-emergent zoonotic threats to humans.

Curr Opin Infect Dis

October 2024

Clinical and Public Health Group, UK Health Security Agency, London, UK.

Purpose Of Review: This review aims to discuss the current state of human infections with Avian Influenza A (H5) and (H9) viruses, to support awareness of the global epidemiology among clinicians and public health professionals interested in emerging respiratory infections.

Recent Findings: Among increasing numbers of detections in avian species of Avian Influenza A(H5N1) clade 2.3.

View Article and Find Full Text PDF

Saintpaul outbreak associated with cantaloupe consumption, the United Kingdom and Portugal, September to November 2023.

Epidemiol Infect

May 2024

Field Service South-East and London, Health Protection Operations Division, UK Health Security Agency, London, UK.

In September 2023, the UK Health Security Agency identified cases of Saintpaul distributed across England, Scotland, and Wales, all with very low genetic diversity. Additional cases were identified in Portugal following an alert raised by the United Kingdom. Ninety-eight cases with a similar genetic sequence were identified, 93 in the United Kingdom and 5 in Portugal, of which 46% were aged under 10 years.

View Article and Find Full Text PDF

To detect SARS-CoV-2 amongst asymptomatic care home staff in England, a dual-technology weekly testing regime was introduced on 23 December 2020. A lateral flow device (LFD) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) test were taken on the same day (day 0) and a midweek LFD test was taken three to four days later. We evaluated the effectiveness of using dual-technology to detect SARS-CoV-2 between December 2020 to April 2021.

View Article and Find Full Text PDF

Shedding and exclusion from childcare in children with Shiga toxin-producing , 2018-2022.

Epidemiol Infect

February 2024

Health Protection Operations, UK Health Security Agency, London, UK.

Excluding children with Shiga toxin-producing (STEC) from childcare until microbiologically clear of the pathogen, disrupts families, education, and earnings. Since PCR introduction, non-O157 STEC serotype detections in England have increased. We examined shedding duration by serotype and transmission risk, to guide exclusion advice.

View Article and Find Full Text PDF

Background: Asymptomatic SARS-CoV-2 testing of hospitalised patients began in April-2020, with twice weekly healthcare worker (HCW) testing introduced in November-2020. Guidance recommending asymptomatic testing was withdrawn in August-2022. Assessing the impact of this decision from data alone is challenging due to concurrent changes in infection prevention and control practices, community transmission rates, and a reduction in ascertainment rate from reduced testing.

View Article and Find Full Text PDF

The evaluation of a multi-day testing approach with antigen lateral flow devices for people eligible for community-based COVID-19 treatments.

J Antimicrob Chemother

November 2023

Clinical and Public Health Group, UK Health Security Agency, Nobel House, 17 Smith Square, London, SW1P 3JR, UK.

Background: COVID-19 therapeutics including antiviral and monoclonal antibody treatments (hereafter 'COVID-19 treatments') require rapid administration to be effective. As part of the community-based antiviral and therapeutic treatment pathway for COVID-19 there has been a move from PCR testing in those eligible to a rapid antigen lateral flow testing regime.

Objectives: To determine whether a multi-day lateral flow device (LFD) testing regime is a feasible alternative to PCR for diagnosing symptomatic patients eligible for COVID-19 treatments.

View Article and Find Full Text PDF

Lessons identified for a future pandemic.

J Antimicrob Chemother

November 2023

Clinical and Public Health Group, United Kingdom Health Security Agency (UKHSA), London, UK.

Pandemics are complex events requiring a coordinated, global response. The response to the pandemic exposed vulnerabilities in system preparedness. Lessons arising from the COVID-19 pandemic are characterized by four broad themes: (i) investment in public health and health infrastructure, (ii) countermeasures (medical and non-medical), (iii) risk communication and public health measures and (iv) investment in people and partnerships.

View Article and Find Full Text PDF

Whole-genome sequencing (WGS) information has played a crucial role in the SARS-CoV-2 (COVID-19) pandemic by providing evidence about variants to inform public health policy. The purpose of this study was to assess the representativeness of sequenced cases compared with all COVID-19 cases in England, between March 2020 and August 2021, by demographic and socio-economic characteristics, to evaluate the representativeness and utility of these data in epidemiological analyses. To achieve this, polymerase chain reaction (PCR)-confirmed COVID-19 cases were extracted from the national laboratory system and linked with WGS data.

View Article and Find Full Text PDF

The plans for a new antimicrobial utilization and resistance national surveillance programme, alongside the development of quality measures and methods to monitor unintended outcomes of antimicrobial stewardship and both public and professional behaviour interventions were published in 2013. Since then, England has published an annual surveillance report including outlining progress against the ambitions of the UK national action plans on antimicrobial resistance (2013 to 2018 and 2019 to 2024). A decade later we provide a brief update on progress so far, with a focus on key highlights from the latest report published in November 2022.

View Article and Find Full Text PDF

Background: Antimicrobial resistance (AMR) is a major global health threat caused by the inappropriate use of antimicrobials in healthcare and other settings. Antimicrobial stewardship (AMS) is a broad multi-component health services intervention that promotes and monitors the judicious use of antimicrobials to preserve their future effectiveness. A main component of AMS is education and training (E&T).

View Article and Find Full Text PDF

Objectives: To understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission risks, perceived risks and the feasibility of risk mitigations from experimental mass cultural events before coronavirus disease 2019 (COVID-19) restrictions were lifted.

Design: Prospective, population-wide observational study.

Setting: Four events (two nightclubs, an outdoor music festival and a business conference) open to Liverpool City Region UK residents, requiring a negative lateral flow test (LFT) within the 36 h before the event, but not requiring social distancing or face-coverings.

View Article and Find Full Text PDF

Prevalence and risk factors of bacterial enteric pathogens in men who have sex with men: A cross-sectional study at the UK's largest sexual health service.

J Infect

January 2023

The National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at University College London, UK; Clinical and Public Health Group, UK Health Security Agency, 61 Colindale Avenue, London, NW9 5EQ, UK.

Article Synopsis
  • A study in London found that 9.8% of men who have sex with men (MSM) tested positive for bacterial enteric pathogens (BEPs), with Enteroaggregative E. coli being the most common.
  • Most MSM with BEPs had a history of bacterial STIs, more sexual partners, and some were on HIV pre-exposure prophylaxis, though gastrointestinal symptoms were rare.
  • The presence of the mphA gene, linked to azithromycin resistance, was notably higher in those with BEPs, suggesting the need for improved antimicrobial stewardship in treating bacterial STIs.
View Article and Find Full Text PDF

Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022.

Euro Surveill

October 2022

UK Health Security Agency Northwest London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.

We investigated a secondary school (11-16 year-olds), a primary school (5-11 year-olds), reception year (4-5 year-olds) and a nursery (2-5 year-olds) following confirmed monkeypox in an adult in each educational setting during June and July 2022. MVA-BN vaccine was offered up to 14 days post exposure to 186 children < 12 years and 21 were vaccinated. No secondary cases occurred among at least 340 exposed students and more than 100 exposed staff during the 28-day follow-up period.

View Article and Find Full Text PDF